This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Specialty Active Pharmaceutical Ingredients Market

Market Insights on Specialty Active Pharmaceutical Ingredients covering sales outlook, demand forecast & up-to-date key trends

Specialty Active Pharmaceutical Ingredients Market By Product Type (Small Molecules API, Peptides API, Carbohydrate Drugs API, Steroidal Drugs API), Consumption (In-house, Outsourced) & Region - Forecast 2020 - 2030

Specialty Active Pharmaceutical Ingredients (API) Market Outlook & Key Findings

  • Specialty active pharmaceutical ingredients (API) market likely to grow at over 7.0 % in 2020, as increasing patent expiry of various branded drugs boosts generics sales in the US and Europe
  • Technological advancement in order to increase production capacity in API manufacturing providing high market potential for specialty active pharmaceutical ingredients (API) in developed markets
  • Low-cost offerings from local players are putting pressures on profit margin of big companies
  • Outbreak of COVID19 pandemic has also led to decrease in the production capability of various specialty API manufacturers including pharmaceutical companies and Contract Manufacturing Organization (CMOs)
Customize this Report

Let us know your requirement to get
100% FREE customization

Development of New Purification Technologies Reducing the Production Cost-Factor

Advancement of analytical methods provides better quantification and characterization of the specialty APIs of interest that also reduce the time and production.

  • For example, the introduction of new LC/MS methods in the last few years which use both - low levels of hexafluoroisopropanol (HFIP) and triethylamine (TEA) as a mobile-phase buffer, drive the purification processes and also reduce time and cost.

Besides, there has been significant development in proprietary chemical processes to scale up manufacturing capabilities that have greatly reduced the cost of producing specialty active pharmaceutical ingredients.

Expansion of Manufacturing Facilities Creating Lucrative Opportunities for Market Growth

Majority of specialty API companies are expanding their manufacturing facilities for specialty active pharmaceutical ingredients (API) to maintain or gain market share. Substantial investments in the expansion of approved specialty active pharmaceutical ingredients (API) is one of the major factors among key players in the specialty active pharmaceutical ingredients (API) market.

For instance, in early 2020, WuXi STA opened oligonucleotide API manufacturing facility in Changzhou, China to cope up with the increasing demand.

In 2018, Corden Pharma expanded operations with new commercial oligonucleotide active pharmaceutical ingredients (API) manufacturing capabilities at its FDA inspected Colorado facility.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Specialty Active Pharmaceutical Ingredients (API) Market is Highly Consolidated Among Key Players

The key market players of specialty active pharmaceutical ingredients (API) market are developing highly innovative approaches and business strategies in order to keep the market significantly consolidated.

The major players of the market are focusing on the development of new technologies, acquisition of small and medium-sized companies and exclusive product licensing to hold their strong position in the market. Besides, new product development, partnerships, distribution agreements are the other strategies followed by the leading market players to dominate themselves in the specialty active pharmaceutical ingredients (API) market.

For instance, in June 2016, Anacor Pharmaceuticals, Inc. a leading pharmaceutical company involved in developing small molecule therapeutics API was acquired by Pfizer Inc.

Small Molecules Segment Remains Key in Specialty Active Pharmaceutical Ingredients (API) Market

Increasing adoption of small molecules (non-biologics) owing to patent expiry and large number of generic drugs in development has resulted in affordable healthcare expenditure which is expected to drive the specialty active pharmaceutical ingredients (API) market.

Growing prevalence of chronic diseases such as cancer, diabetes, cardiovascular, and the infectious diseases is also providing potential opportunities to the market player for developing small molecule APIs in specialty active pharmaceutical ingredients (API) market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Complex Manufacturing Process and Stringent Regulations: Key Challenges for Specialty Active Pharmaceutical Ingredients (API) Market Players

Developing specialty active pharmaceutical ingredients can be complex due to the requirement of multiple production stages and the existence of limited patents of branded pharmaceuticals.

In addition, the stringent government regulations on quality assessment of specialty APIs and increase in supply chain security issues in the emerging countries imposing large impact on the cost of specialty APIs hence expected to hamper the growth of specialty active pharmaceutical ingredients (API) market. As such, the new entrants willing to enter the specialty active pharmaceutical ingredients market are facing financial challenges.

Type II DMFs to Keep the Cash Registers Ringing

Specialty API Market is shifting from Type I DMFs (Drug Master Files) to Type II DMFs Type II DMF drug documents drug substances, substance materials and intermediates used in drug product’s penetration. Extensive DMF filings could be credited to growing investments by Asia-Pacific-based players. Also, SAHPRA, Brazilian Health Regulatory Agency, MHRA, TGA, and U.S. FDA are into approvals of DMFs; thereby driving the market altogether.

Specialty Active Pharmaceutical Ingredients (API): Region-wise Analysis

Europe, followed by North America, continues to be the most lucrative market for specialty active pharmaceutical ingredients (APIs) due to high adoption rate of innovative/patented medicines. The U. S. remains most lucrative country in global specialty active pharmaceutical ingredients (API) market and it has consistently shown significant annual growth rates, and the market is set to grow at over 5.5% in 2020.

Specialty Active Pharmaceutical Ingredients Market Download Report Brochure

Outside of Europe and North America, Japan, China, India and GCC Countries represent significant opportunities for specialty active pharmaceutical ingredients (API) market players. The high patient population and growing demand for affordable healthcare facilities are expected to provide huge opportunities for the manufacturers to expand their business in this region. These economies like India and China are at the forefront on the count of adopting generics. Latin America is encouraging incorporation of novel regional players; which is expected to have specialty APIs as placeholders herein.

Contract manufacturing is also picking up across all the geographies. North America and Oceania are already in the saturation mode. There is more occurrence of chronic diseases in South Asia, East Asia, and MEA. This is another factor expected to create a major overhaul here.

Leading Players in Specialty Active Pharmaceutical Ingredients (API) Market

The specialty active pharmaceutical ingredients (API) market is witnessing a gradual entry of new players at a local or regional level. An estimated 20+ specialty active pharmaceutical ingredients (API) market players are actively involved in research and developments, technological advancement, and e-commerce to hold a distinct market identity. Some of the key players in the specialty active pharmaceutical ingredients (API) market are,

Americas

  • Inalco Pharmaceuticals
  • Sussex Research Laboratories Inc.
  • PolyPeptide Laboratories
  • Nitto Denko Avecia Inc.
  • Dalton Pharma Services
  • Amneal Pharmaceuticals, Inc.
  • Mylan NV


Europe

  • Corden Pharma International GmbH
  • Pepscan Holding NV
  • Provence Technologies Group
  • BCN Peptides S.A.
  • Senn Chemicals AG.
  • Santaris Pharma A/S
  • Sanofi
  • Pfizer Inc.
  • Jazz Pharmaceuticals, Inc.

Asia Pacific

  • ST Pharm. Co. Ltd
  • Symbiotec Pharma Lab Pvt. Ltd.
  • Cadila Healthcare Ltd.
  • Lupin Ltd.
     
  • Amneal Pharmaceuticals, Inc.

They do operate all across “Specialty” and “Generics”. The company is known for APIs’ captive manufacturing for their own set of finished products.

  • Cadila Healthcare Ltd.

The company is known for having offered 38 intermediates and APIs across therapeutic categories.

  • Jazz Pharmaceuticals Plc

The company’s unified business segment does pave the way for a broad spectrum of APIs to produce finished products.

  • Lupin Ltd.

The company produces as well as commercializes finished pharmaceutical products and offers APIs for these products.

  • Mylan NV

The business segments Mylan caters to includes Rx/Bx, Gx, and OTC. The products for which it offers APIs address therapeutic areas like proton pump inhibitors, anti-fungals, anti-diebetics, anti-virals, cardiovascular, anti-asthamatics/anti-histamines, central nervous system agents, anti-bacterials, and HIV/AIDs.

*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report

Specialty Active Pharmaceutical Ingredients (API): The Way Forward

The long-term outlook on specialty active pharmaceutical ingredients (API) market remains bullish, with FMI’s analysis estimating revenues to grow at over 7.0% consistently. The global increase in the patient pool having chronic ailments and rising infectious diseases around the world has created huge long-term demand of the small molecule active pharmaceutical ingredients (API) in the specialty active pharmaceutical ingredients (API) global market. Plus, growing demand for generic drugs is also expected to gain traction in the long-term market opportunities.

Specialty active pharmaceutical ingredients (API) manufacturers will need to focus on cost management and product sale and distribution to target wider geography. Portfolio strengthening and development of specialty active pharmaceutical ingredients (API) for wider application such in the pediatric and geriatric patient base are the key strategies needed to be focused by the leading industry players. In addition, to increase sales in lucrative markets, collaborations with local manufacturers is much needed.

Key Segments of Specialty Active Pharmaceutical Ingredients (API) Market

Product Type:

  • Small Molecules API
    • Controlled Substances API
    • HPAPI
  • Peptides API
  • Carbohydrate Drugs API
  • Steroidal Drugs API

Consumption:

  • In-house
  • Outsourced

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Frequently Asked Questions

The specialty-active pharmaceutical ingredients market is predicted to grow at 8.6% CAGR through 2032.

North America is likely to lead the specialty-active pharmaceutical ingredients market.

The specialty-active pharmaceutical ingredients market is expected to surpass US$ 478.52 Bn by 2032.

The specialty-active pharmaceutical ingredients market size is anticipated to be over US$ 209.7 Bn in 2022.

Table of Content

1. Executive Summary

     1.1. Global Market Outlook

     1.2. Demand Side Trends

     1.3. Supply Side Trends

     1.4. Analysis and Recommendations

2. Market Overview

     2.1. Market Coverage / Taxonomy

     2.2. Market Definition / Scope / Limitations

     2.3. Inclusions and Exclusions

     2.4. Detailed COVID19 Impact Analysis

         2.4.1. Prevalence

         2.4.2. Pipeline Vaccines

         2.4.3. Pipeline Drugs

         2.4.4. Impact on Healthcare Industry

3. Key Market Trends

     3.1. Key Trends Impacting the Market

     3.2. Product Innovation / Development Trends

4. Market Background

     4.1. Macro-Economic Factors

     4.2. Forecast Factors - Relevance & Impact

     4.3. Market Dynamics

         4.3.1. Drivers

         4.3.2. Restraints

         4.3.3. Opportunities

     4.4. COVID19 Crisis Analysis

         4.4.1. Current COVID19 Statistics and Probable Future Impact

         4.4.2. Current GDP Projection and Probable Impact

         4.4.3. Current Economic Projection as compared to 2008 Economic analysis

         4.4.4. COVID19 and Impact Analysis

             4.4.4.1. Revenue By Product Type

             4.4.4.2. Revenue By Country

         4.4.5. 2020 Market Scenario

         4.4.6. Quarter by Quarter Forecast

         4.4.7. Projected recovery Quarter 

5. Market Context

     5.1. Product USPs/ Features

     5.2. Product  Adoption / Usage Analysis

     5.3. Regulatory Scenario, By Region

     5.4. Supply-Chain Analysis

6. Global Specialty Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Analysis 2015–2019 and Forecast, 2020–2030

     6.1. Historical Market Value (US$ Mn) Analysis, 2015–2019

     6.2. Current and Future Market Value (US$ Mn) Projections, 2020–2030

         6.2.1. Y-o-Y Growth Trend Analysis

         6.2.2. Opportunity Analysis, 2020–2030

7. Global Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030, By Product Type

     7.1. Introduction / Key Findings

     7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2015–2019

     7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2020–2030

         7.3.1. Small Molecules API

             7.3.1.1. Controlled Substances API

             7.3.1.2. HPAPI

         7.3.2. Peptides API

         7.3.3. Carbohydrate Drugs API

         7.3.4. Steroidal Drugs API

     7.4. Market Attractiveness Analysis By Product Type

8. Global Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030, by Consumption

     8.1. Introduction / Key Findings

     8.2. Historical Market Size (US$ Mn) Analysis By Consumption, 2015–2019

     8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Consumption, 2020–2030

         8.3.1. In-house

         8.3.2. Outsourced

     8.4. Market Attractiveness Analysis By Consumption

9. Global Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030, by Region

     9.1. Introduction / Key Findings

     9.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2019

     9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020–2030

         9.3.1. North America

         9.3.2. Latin America

         9.3.3. Europe

         9.3.4. East Asia

         9.3.5. South Asia

         9.3.6. Oceania

         9.3.7. Middle East and Africa

     9.4. Market Attractiveness Analysis By Region

10. North America Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030

     10.1. Introduction

     10.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

     10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030

         10.3.1.  By Country

             10.3.1.1. U.S.

             10.3.1.2. Canada

         10.3.2. By Product Type

         10.3.3. By Consumption

     10.4. Market Attractiveness Analysis

     10.5. Key Market Participants - Intensity Mapping

     10.6. Drivers and Restraints - Impact Analysis

11. Latin America Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030

     11.1. Introduction

     11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

     11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030

         11.3.1.  By Country

             11.3.1.1. Brazil

             11.3.1.2. Mexico

             11.3.1.3. Argentina

             11.3.1.4. Rest of Latin America

         11.3.2. By Product Type

         11.3.3. By Consumption

     11.4. Market Attractiveness Analysis

     11.5. Key Market Participants - Intensity Mapping

     11.6. Drivers and Restraints - Impact Analysis

12. Europe Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030

     12.1. Introduction

     12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

     12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030

         12.3.1.  By Country

             12.3.1.1. Germany

             12.3.1.2. Italy

             12.3.1.3. France

             12.3.1.4. U.K.

             12.3.1.5. Spain

             12.3.1.6. BENELUX

             12.3.1.7. Russia

             12.3.1.8. Rest of Europe

         12.3.2. By Product Type

         12.3.3. By Consumption

     12.4. Market Attractiveness Analysis

     12.5. Key Market Participants - Intensity Mapping

     12.6. Drivers and Restraints - Impact Analysis

13. South Asia Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030

     13.1. Introduction

     13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

     13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030

         13.3.1.  By Country

             13.3.1.1. India

             13.3.1.2. Thailand

             13.3.1.3. Indonesia

             13.3.1.4. Malaysia

             13.3.1.5. Rest of South Asia

         13.3.2. By Product Type

         13.3.3. By Consumption

     13.4. Market Attractiveness Analysis

     13.5. Key Market Participants - Intensity Mapping

     13.6. Drivers and Restraints - Impact Analysis

14. East Asia Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030

     14.1. Introduction

     14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

     14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030

         14.3.1.  By Country

             14.3.1.1. China

             14.3.1.2. Japan

             14.3.1.3. South Korea

         14.3.2. By Product Type

         14.3.3. By Consumption

     14.4. Market Attractiveness Analysis

     14.5. Key Market Participants - Intensity Mapping

     14.6. Drivers and Restraints - Impact Analysis

15. Oceania Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030

     15.1. Introduction

     15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

     15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030

         15.3.1.  By Country

             15.3.1.1. Australia

             15.3.1.2. New Zealand

         15.3.2. By Product Type

         15.3.3. By Consumption

     15.4. Market Attractiveness Analysis

     15.5. Key Market Participants - Intensity Mapping

     15.6. Drivers and Restraints - Impact Analysis

16. Middle East and Africa Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030

     16.1. Introduction

     16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

     16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030

         16.3.1.  By Country

             16.3.1.1. GCC Countries

             16.3.1.2. Turkey

             16.3.1.3. South Africa

             16.3.1.4. Rest of Middle East and Africa

         16.3.2. By Product Type

         16.3.3. By Consumption

     16.4. Market Attractiveness Analysis

     16.5. Key Market Participants - Intensity Mapping

     16.6. Drivers and Restraints - Impact Analysis

17. Key and Emerging Countries Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030

     17.1. Introduction

         17.1.1. Market Value Proportion Analysis, By Key Countries

         17.1.2. Global Vs. Country Growth Comparison

     17.2. U.S. Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.2.1. By Product Type

         17.2.2. By Consumption

     17.3. Canada Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.3.1. By Product Type

         17.3.2. By Consumption

     17.4. Mexico Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.4.1. By Product Type

         17.4.2. By Consumption

     17.5. Brazil Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.5.1. By Product Type

         17.5.2. By Consumption

     17.6. U.K. Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.6.1. By Product Type

         17.6.2. By Consumption

     17.7. Germany Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.7.1. By Product Type

         17.7.2. By Consumption

     17.8. France Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.8.1. By Product Type

         17.8.2. By Consumption

     17.9. Italy Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.9.1. By Product Type

         17.9.2. By Consumption

     17.10. Spain Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.10.1. By Product Type

         17.10.2. By Consumption

     17.11. BENELUX Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.11.1. By Product Type

         17.11.2. By Consumption

     17.12. Russia Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.12.1. By Product Type

         17.12.2. By Consumption

     17.13. China Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.13.1. By Product Type

         17.13.2. By Consumption

     17.14. Japan Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.14.1. By Product Type

         17.14.2. By Consumption

     17.15. South Korea Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.15.1. By Product Type

         17.15.2. By Consumption

     17.16. India Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.16.1. By Product Type

         17.16.2. By Consumption

     17.17. ASEAN Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.17.1. By Product Type

         17.17.2. By Consumption

     17.18. Australia Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.18.1. By Product Type

         17.18.2. By Consumption

     17.19. New Zealand Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.19.1. By Product Type

         17.19.2. By Consumption

     17.20. GCC Countries Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.20.1. By Product Type

         17.20.2. By Consumption

     17.21. Turkey Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.21.1. By Product Type

         17.21.2. By Consumption

     17.22. South Africa Specialty Active Pharmaceutical Ingredients (API) Market Analysis

         17.22.1. By Product Type

         17.22.2. By Consumption

18. Market Structure Analysis

     18.1. Market Analysis by Tier of Companies 

     18.2. Market Share Analysis of Top Players

     18.3. Market Presence Analysis

         18.3.1. Regional Footprint by Players

         18.3.2. Product Foot print by Players

         18.3.3. Channel Foot Print by Players

19. Competition Analysis

     19.1. Competition Dashboard

     19.2. Competition Benchmarking

     19.3. Competition Deep Dive (Tentative List)

         19.3.1. Corden Pharma International GmbH

             19.3.1.1. Overview

             19.3.1.2. Product  Portfolio

             19.3.1.3. Profitability by Market Segments (Product/Channel/Region)

             19.3.1.4. Sales Footprint

             19.3.1.5. Strategy Overview

                 19.3.1.5.1. Marketing Strategy

                 19.3.1.5.2. Product Strategy

                 19.3.1.5.3. Channel Strategy

         19.3.2. Pepscan Holding NV

             19.3.2.1. Overview

             19.3.2.2.  Product  Portfolio

             19.3.2.3. Profitability by Market Segments (Product/Channel/Region)

             19.3.2.4. Sales Footprint

             19.3.2.5. Strategy Overview

                 19.3.2.5.1. Marketing Strategy

                 19.3.2.5.2. Product Strategy

                 19.3.2.5.3. Channel Strategy

         19.3.3. Provence Technologies Group

             19.3.3.1. Overview

             19.3.3.2.  Product  Portfolio

             19.3.3.3. Profitability by Market Segments (Product/Channel/Region)

             19.3.3.4. Sales Footprint

             19.3.3.5. Strategy Overview

                 19.3.3.5.1. Marketing Strategy

                 19.3.3.5.2. Product Strategy

                 19.3.3.5.3. Channel Strategy

         19.3.4. BCN Peptides S.A.

             19.3.4.1. Overview

             19.3.4.2. Product  Portfolio

             19.3.4.3. Profitability by Market Segments (Product/Channel/Region)

             19.3.4.4. Sales Footprint

             19.3.4.5. Strategy Overview

                 19.3.4.5.1. Marketing Strategy

                 19.3.4.5.2. Product Strategy

                 19.3.4.5.3. Channel Strategy

         19.3.5. Senn Chemicals AG.

             19.3.5.1. Overview

             19.3.5.2. Product  Portfolio

             19.3.5.3. Profitability by Market Segments (Product/Channel/Region)

             19.3.5.4. Sales Footprint

             19.3.5.5. Strategy Overview

                 19.3.5.5.1. Marketing Strategy

                 19.3.5.5.2. Product Strategy

                 19.3.5.5.3. Channel Strategy

         19.3.6. Santaris Pharma A/S

             19.3.6.1. Overview

             19.3.6.2. Product  Portfolio

             19.3.6.3. Profitability by Market Segments (Product/Channel/Region)

             19.3.6.4. Sales Footprint

             19.3.6.5. Strategy Overview

                 19.3.6.5.1. Marketing Strategy

                 19.3.6.5.2. Product Strategy

                 19.3.6.5.3. Channel Strategy

         19.3.7. Sanofi

             19.3.7.1. Overview

             19.3.7.2. Product  Portfolio

             19.3.7.3. Profitability by Market Segments (Product/Channel/Region)

             19.3.7.4. Sales Footprint

             19.3.7.5. Strategy Overview

                 19.3.7.5.1. Marketing Strategy

                 19.3.7.5.2. Product Strategy

                 19.3.7.5.3. Channel Strategy

         19.3.8. Pfizer Inc.

             19.3.8.1. Overview

             19.3.8.2. Product  Portfolio

             19.3.8.3. Profitability by Market Segments (Product/Channel/Region)

             19.3.8.4. Sales Footprint

             19.3.8.5. Strategy Overview

                 19.3.8.5.1. Marketing Strategy

                 19.3.8.5.2. Product Strategy

                 19.3.8.5.3. Channel Strategy

 20. Assumptions and Acronyms Used

 21. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Expenditure on Health (% of GDP) by Country, 2016-2021

Table 2: Expenditure on Health (% of GDP) by Country, 2016-2021

Table 3: Global Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 5: Global Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Consumption

Table 6: Global Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region

Table 7: North America Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 8: North America Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 9: North America Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Consumption

Table 10: Latin America Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 11: Latin America Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 12: Latin America Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Consumption

Table 13: Europe Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 14: Europe Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 15: Europe Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Consumption

Table 16: South Asia Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 17: South Asia Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 18: South Asia Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Consumption

Table 19: East Asia Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 20: East Asia Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 21: East Asia Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Consumption

Table 22: Oceania Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 23: Oceania Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 24: Oceania Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Consumption

Table 25: MEA Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 26: MEA Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 27: MEA Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Consumption

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Specialty API Market Historical Market Volume (Mn Units) Analysis, 2015-2019

Figure 2: Global Specialty API Current and Future Market Volume (Mn Units), 2020-2030 & Y-o-Y Growth Trend Analysis

 Figure 3: Global Specialty API Market Historical Market Value (US$ Mn) Analysis, 2015-2019

Figure 4: Global Specialty API Current and Future Market Value (US$ Mn), 2020-2030 & Y-o-Y Growth Trend Analysis

Figure 5: Specialty API Market Absolute $ Opportunity, 2014–2029

Figure 6: Global Specialty API Market Share Analysis (%) By Product Type, 2020 & 2030

Figure 7: Global Specialty API Market Y-o-Y Growth (%) By Product Type, 2020-2030

Figure 8: Global Specialty API Market Attractiveness Analysis, By Product Type

Figure 9: Global Specialty API Market Share Analysis (%) By Consumption, 2020 & 2030

Figure 10: Global Specialty API Market Y-o-Y Growth (%) By Consumption, 2020-2030

Figure 11: Global Specialty API Market Attractiveness Analysis, By Consumption

Figure 12: Global Specialty API Market Share Analysis (%) By Region, 2020 & 2030

Figure 13: Global Specialty API Market Y-o-Y Growth (%) By Region, 2020-2030

Figure 14: Global Specialty API Market Attractiveness Analysis, By Region

Figure 15: North America Specialty API Market Share, By Product Type (2019)

Figure 16: North America Specialty API Market Share, By Consumption (2019)

Figure 17: North America Specialty API Market Share, By Country (2019)

Figure 18: North America Specialty API Market size (US$ Mn) 2020 & 2030

Figure 19: North America Specialty API Market Value (US$ Mn) Analysis, 2015–2019

Figure 20: North America Specialty API Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 21: North America Specialty API Market Attractiveness Analysis, By Product Type

Figure 22: North America Specialty API Market Attractiveness Analysis, By Consumption

Figure 23: North America Specialty API Market Attractiveness Analysis, By Country

Figure 24: Latin America Specialty API Market Share, By Product Type (2019)

Figure 25: Latin America Specialty API Market Share, By Consumption (2019)

Figure 26: Latin America Specialty API Market Share, By Country (2019)

Figure 27: Latin America Specialty API Market size (US$ Mn) 2020 & 2030

Figure 28: Latin America Specialty API Market Value (US$ Mn) Analysis, 2015–2019

Figure 29: Latin America Specialty API Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 30: Latin America Specialty API Market Attractiveness Analysis, By Product Type

Figure 31: Latin America Specialty API Market Attractiveness Analysis, By Consumption

Figure 32: Latin America Specialty API Market Attractiveness Analysis, By Country

Figure 33: Europe Specialty API Market Share, By Product Type (2019)

Figure 34: Europe Specialty API Market Share, By Consumption (2019)

Figure 35: Europe Specialty API Market Share, By Country (2019)

Figure 36: Europe Specialty API Market size (US$ Mn) 2020 & 2030

Figure 37: Europe Specialty API Market Value (US$ Mn) Analysis, 2015–2019

Figure 38: Europe Specialty API Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 39: Europe Specialty API Market Attractiveness Analysis, By Product Type

Figure 40: Europe Specialty API Market Attractiveness Analysis, By Consumption

Figure 41: Europe Specialty API Market Attractiveness Analysis, By Country

Figure 42: South Asia Specialty API Market Share, By Product Type (2019)

Figure 43: South Asia Specialty API Market Share, By Consumption (2019)

Figure 44: South Asia Specialty API Market Share, By Country (2019)

Figure 45: South Asia Specialty API Market size (US$ Mn) 2020 & 2030

Figure 46: South Asia Specialty API Market Value (US$ Mn) Analysis, 2015–2019

Figure 47: South Asia Specialty API Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 48: South Asia Specialty API Market Attractiveness Analysis, By Product Type

Figure 49: South Asia Specialty API Market Attractiveness Analysis, By Consumption

Figure 50: South Asia Specialty API Market Attractiveness Analysis, By Country

Figure 51: East Asia Specialty API Market Share, By Product Type (2019)

Figure 52: East Asia Specialty API Market Share, By Consumption (2019)

Figure 53: East Asia Specialty API Market Share, By Country (2019)

Figure 54: East Asia Specialty API Market size (US$ Mn) 2020 & 2030

Figure 55: East Asia Specialty API Market Value (US$ Mn) Analysis, 2015–2019

Figure 56: East Asia Specialty API Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 57: East Asia Specialty API Market Attractiveness Analysis, By Product Type

Figure 58: East Asia Specialty API Market Attractiveness Analysis, By Consumption

Figure 59: East Asia Specialty API Market Attractiveness Analysis, By Country

Figure 60: Oceania Specialty API Market Share, By Product Type (2019)

Figure 61: Oceania Specialty API Market Share, By Consumption (2019)

Figure 62: Oceania Specialty API Market Share, By Country (2019)

Figure 63: Oceania Specialty API Market size (US$ Mn) 2020 & 2030

Figure 64: Oceania Specialty API Market Value (US$ Mn) Analysis, 2015–2019

Figure 65: Oceania Specialty API Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 66: Oceania Specialty API Market Attractiveness Analysis, By Product Type

Figure 67: Oceania Specialty API Market Attractiveness Analysis, By Consumption

Figure 68: Oceania Specialty API Market Attractiveness Analysis, By Country

Figure 69: MEA Specialty API Market Share, By Product Type (2019)

Figure 70: MEA Specialty API Market Share, By Consumption (2019)

Figure 71: MEA Specialty API Market Share, By Country (2019)

Figure 72: MEA Specialty API Market size (US$ Mn) 2020 & 2030

Figure 73: MEA Specialty API Market Value (US$ Mn) Analysis, 2015–2019

Figure 74: MEA Specialty API Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 75: MEA Specialty API Market Attractiveness Analysis, By Product Type

Figure 76: MEA Specialty API Market Attractiveness Analysis, By Consumption

Figure 77: MEA Specialty API Market Attractiveness Analysis, By Country

Figure 78: U.S. Specialty API Market size (US$ Mn) 2020 & 2030

Figure 79: U.S. Specialty API Market Share, By Product Type (2019)

Figure 80: U.S. Specialty API Market Share, By Product Type (2019)

Figure 81: Brazil Specialty API Market size (US$ Mn) 2020 & 2030

Figure 82: Brazil Specialty API Market Share, By Product Type (2019)

Figure 83: Brazil Specialty API Market Share, By Product Type (2019)

Figure 84: Germany Specialty API Market size (US$ Mn) 2020 & 2030

Figure 85: Germany Specialty API Market Share, By Product Type (2019)

Figure 86: Germany Specialty API Market Share, By Product Type (2019)

Figure 87: U.K. Specialty API Market size (US$ Mn) 2020 & 2030

Figure 88: U.K. Specialty API Market Share, By Product Type (2019)

Figure 89: U.K. Specialty API Market Share, By Product Type (2019)

Figure 90: India Specialty API Market size (US$ Mn) 2020 & 2030

Figure 91: India Specialty API Market Share, By Product Type (2019)

Figure 92: India Specialty API Market Share, By Product Type (2019)

Figure 93: China Specialty API Market size (US$ Mn) 2020 & 2030

Figure 94: China Specialty API Market Share, By Product Type (2019)

Figure 95: China Specialty API Market Share, By Product Type (2019)

Figure 96: Japan Specialty API Market size (US$ Mn) 2020 & 2030

Figure 97: Japan Specialty API Market Share, By Product Type (2019)

Figure 98: Japan Specialty API Market Share, By Product Type (2019)

Figure 99: GCC Countries Specialty API Market size (US$ Mn) 2020 & 2030

Figure 100: GCC Countries Specialty API Market Share, By Product Type (2019)

Figure 101: GCC Countries Specialty API Market Share, By Product Type (2019)

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Specialty Active Pharmaceutical Ingredients Market